.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Healthtrust
Chinese Patent Office
Cipla
US Army
Medtronic
Colorcon
Citi
Queensland Health
Mallinckrodt

Generated: December 17, 2017

DrugPatentWatch Database Preview

Indapamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for indapamide and what is the scope of indapamide patent protection?

Indapamide
is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Amerigen Pharms Ltd, Ani Pharms Inc, Mylan, Mylan Pharms Inc, Sandoz, Teva, Watson Labs, and Sanofi Aventis Us, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for indapamide. Eleven suppliers are listed for this compound.

Pharmacology for indapamide

Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for indapamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsLOZOLindapamideTABLET;ORAL018538-002Apr 29, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
MylanINDAPAMIDEindapamideTABLET;ORAL074461-002Mar 26, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms IncINDAPAMIDEindapamideTABLET;ORAL075105-001Jul 23, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncINDAPAMIDEindapamideTABLET;ORAL074498-002Feb 12, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
TevaINDAPAMIDEindapamideTABLET;ORAL074665-002Apr 4, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsLOZOLindapamideTABLET;ORAL018538-001Jul 6, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncINDAPAMIDEindapamideTABLET;ORAL074299-001Jul 27, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms IncINDAPAMIDEindapamideTABLET;ORAL074299-002Apr 29, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis ElizabethINDAPAMIDEindapamideTABLET;ORAL074722-002Jun 17, 1996ABRXNoNo► Subscribe► Subscribe► Subscribe
Amerigen Pharms LtdINDAPAMIDEindapamideTABLET;ORAL075201-002Dec 4, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: indapamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsLOZOLindapamideTABLET;ORAL018538-001Jul 6, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Chubb
Baxter
Dow
Chinese Patent Office
Covington
Johnson and Johnson
Deloitte
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot